The novel treatment of this peptide represents a significant breakthrough in the management of the condition. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide343988.elbloglibre.com/42430127/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment